Experience

Sintetica

• Switzerland
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• President, Sintetica US

  • Feb 2022 - Present



Barclay Life Sciences Consulting LLC

• Philadelphia, Pennsylvania, United States

• Managing Partner

  • Nov 2021 - Present



STI PHARMA

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• President, CFO and Chief Commercial Officer

  • Sep 2019 - Nov 2021

  -Responsible for all the operations of the company including Commercial, Scientific Affairs, Manufacturing, Supply Chain, Finance, and Business Development. Provide the vision and strategy for the company translated into a 5-year Strategic Plan. Responsible for the execution of all business activities and for bringing together all of our operational assets. -Responsible for all aspects of capital fundraising including working with private equity, venture debt, strategic alliances, and commercial banks. -Launched STI’s first four injectable products, securing market leadership position with over 20% market share as 4th market entrant on the company's first launch securing multiple GPO, IDN, and direct to Hospital contracts. -Led all launch efforts including market strategy, pricing, customer targeting, contract negotiation. -Serve as leader of all commercial activities including product performance for portfolio of oral solid dose and injectable products. -Rebuilt Sales team, established all commercial processes and analytics. -Reset and updated R&D product pipeline, doubled number of products in pipeline and established unique co-development program with key customer.  -Lead all Business Development activities, including establishing relationships, product analysis, deal structure, valuation, and all negotiations. Currently in the due diligence stage on multiple acquisitions. Show less



Mylan

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• President, Mylan Institutional

  • Oct 2016 - Sep 2019

  Leadership of the commercial activities including strategy, operations, and execution of the business unit budget and strategic plans.- Successfully grew revenues by 20% in 2018 to $1B, launched Mylan's first Biosimilar (Fulphila, a biosimialr to Neulasta), established key partnerships with GPO/IDN/ Wholesale customers, launched over 20 injectable products.- Responsible for all business unit activities including sales, marketing, manufacturing, operations, business development, product selection and development.- Ownership of market entry strategy, pricing and contracting decisions and customer negotiations. - Created siginificant value building strong customer relationships and adding unique programs around the portfolio including incentive and launch programs. Show less

• CFO, North America

  • Feb 2015 - Oct 2016

  Responsible for all financial activities of the North American region including the generic and branded divisions in the US and Canada totaling over $4B in revenue.-Partnered with the President of North America in overseeing the commercial activities of the region including business unit goals and managing performance, product launch strategies, customer strategies and contracts and pricing decisions.-Lead in establishing the 5 year strategic plan, annual budget, quarterly forecast, and ongoing performance measurement.- Managed regional investments in business development and selling, marketing , and G&A. Responsible for expense allocation and return on investment analysis for the regaions four business units- Played lead role in divesting assets and business transformation activities, portfolio alignment, and business assesments to position for future growth.-Guided the region for sustained growth and delivered 10%+ growth in each year as CFO Show less

• CFO, MPI

  • Mar 2014 - Feb 2015

• Senior Director of Finance and MPI Controller

  • Jan 2013 - Mar 2014

• Director, North American Strategy

  • Sep 2012 - Jan 2013



Ex- Viropharma linkedin page

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Controller & Head of Financial Planning and Analysis

  • Jan 2011 - Sep 2012

  Responsible for leadership of the global accounting function. Managed the accounting team (including additional functional reports worldwide), financial statement preparation and consolidated results.-Manage all aspects of accounting, cost accounting, accounts payable, accounts receivable, payroll, and financial planning and analysis.-Overall responsibility for specific financial aspects of the business related to cash flow planning, cost alignment and control and financial analysis.

• Head of Commercial Operations and Commercial Finance

  • Oct 2008 - Jan 2011

  Directed the development of the strategic plan, annual budget, and quarterly forecasts of the consolidated business. Led FP&A including support of the sales, marketing, managed care, manufacturing, and supply chain groups.-Responsible for full P&L including forecasting, budgeting and analysis of over $400 million in Revenue. Translated Commercial and Operational Plans into Financial Forecasts and Budgets linked directly to Corporate Strategy.-Led all strategic planning of the operational and commercial functions of the organization including setting goals, establishing key metrics, demand planning, supplier contract negotiations, sales forecasting, market research, ROI analysis of marketing initiatives, including alignment across all functions.- Ongoing support of Executive Team as a financial business partner in determining strategies on supply, manufacturing, and commercial activities. Active participant in weekly management team meetings and in presentations to Board of Directors. Show less



Teva Pharmaceuticals

• Israel
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Associate Director, Financial Planning and Analysis

  • Mar 2008 - Oct 2008

  Served in a leadership position responsible for all aspects of planning and analysis for the U.S. business unit, (over $4B in yearly revenue.) Drove financial growth by partnering across all functional organizations with a specific focus on the Commercial group which served as a catalyst for aligned work plans.-Directed all activities associated with financial analysis, reporting, multi-year work plans, and quarterly forecasting. Worked closely with CFO and President of Teva North America on all aspects of financial performance of business unit.-Delivered analysis of business performance to US senior management team and Corporate Finance Department in Israel through periodic presentations Show less

• Senior Manager – Financial Planning and Analysis

  • Nov 2007 - Mar 2008

• Manager – Financial Planning and Analysis

  • Mar 2007 - Nov 2007

• Financial Analyst – Financial Planning and Analysis

  • Mar 2005 - Mar 2007